Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Publication year range
1.
Clin. biomed. res ; 42(2): 165-175, 2022.
Article in Portuguese | LILACS | ID: biblio-1391568

ABSTRACT

RESUMO: O edema macular diabético é uma das principais causas de baixa visual no mundo e a indicação mais frequente de injeções intravítreas no Hospital de Clínicas de Porto Alegre. O tratamento com injeção intra-vítrea de medicamentos anti-vascular endothelial growth factor, incluindo o bevacizumaberevolucionou o desfecho visual destes pacientes às custas de múltiplas aplicações mensais. Assim como em outros centros, discrepâncias entre condutas da equipe assistencial e dificuldades logísticas acabam comprometendo a efetividade do tratamento. Portanto, desenvolvemos um protocolo de tratamento para a doença embasado na literatura, estabelecendo critérios de inclusão, exclusão, regime de tratamento e seguimento do paciente. Com isto, esperamos otimizar a efetividade e assistência do paciente com edema macular diabético.


ABSTRACT: Diabetic macular edema is one of the leading causes of visual impairment worldwide and the most common indication for intravitreal injections at the Hospital de Clínicas de Porto Alegre. Treatment with intravitreal injection of anti-vascular endothelial growth factor drugs, including bevacizumab, has revolutionized patient outcome at the expense of multiple monthly injections. As in other hospitals, discrepancies in health team conduct and logistical difficulties compromise treatment effectiveness. Therefore, we developed a literature-based treatment protocol for diabetic macular edema, in which we established criteria for patient inclusion and exclusion, treatment regimen, and patient follow-up. We expect the treatment protocol to optimize patient care effectiveness in diabetic macular edema.


Subject(s)
Humans , Macular Edema/drug therapy , Diabetic Retinopathy/complications , Intravitreal Injections/methods , Clinical Protocols , Treatment Outcome , Bevacizumab/administration & dosage
2.
Clin. biomed. res ; 41(4): 354-361, 2021. tab
Article in Portuguese | LILACS | ID: biblio-1349425

ABSTRACT

A degeneração macular relacionada com a idade na forma neovascular é uma das principais causas de cegueira no mundo e a segunda indicação mais frequente de injeções intravítreas no Hospital de Clínicas de Porto Alegre. O tratamento com injeção intra-vítrea de medicamentos supressores do fator de crescimento endotelial (anti-vascular endothelial growth factor, anti-VEGF), incluindo o bevacizumabe, revolucionou o desfecho visual destes pacientes às custas de múltiplas aplicações mensais. Assim como em outros centros, discrepâncias entre condutas da equipe assistencial e dificuldades logísticas acabam comprometendo a efetividade do tratamento. Portanto, desenvolvemos um protocolo de tratamento para a DMRI-n embasado na literatura, estabelecendo critérios de inclusão, exclusão, regime de tratamento e seguimento do paciente. Com isto, esperamos otimizar a efetividade e assistência do paciente com DMRI-n. (AU)


Age-related macular degeneration in the neovascular form is one of the main causes of blindness in the world and the second most frequent indication of intravitreal injections at Hospital de Clínicas de Porto Alegre. Treatment with intravitreal injection of antivascular endothelial growth factor agents, including bevacizumab, revolutionized the visual outcome of these patients at the expense of multiple monthly applications. As in other centers, discrepancies in care team's approaches and logistical difficulties compromise the effectiveness of treatment. Therefore, we developed a treatment protocol for neovascular age-related macular degeneration (nAMD) based on the literature, establishing criteria for inclusion, exclusion, treatment regimen and patient follow-up. We hope to optimize the effectiveness of treatment in patients with nAMD. (AU)


Subject(s)
Clinical Protocols , Intravitreal Injections , Macular Degeneration/therapy , Bevacizumab/therapeutic use
3.
Clin. biomed. res ; 40(3): 173-183, 2020. tab
Article in Portuguese | LILACS | ID: biblio-1248272

ABSTRACT

A injeção intravítrea é o procedimento oftalmológico mais realizado no mundo. Através dessa técnica é possível administrar medicamentos para o segmento posterior do olho, sendo a via de escolha para o tratamento da maioria das patologias coriorretinianas. O evento ocular adverso mais grave é a endoftalmite pós injeção. Diversas medidas foram sugeridas para diminuição do risco dessa complicação, com evidências variáveis. Tendo em vista o grande número de injeções realizado em nosso serviço de oftalmologia do Hospital de Clínicas de Porto Alegre (HCPA), realizamos uma revisão da literatura com o objetivo de definir as melhores práticas. Nós descrevemos a evidência disponível para os principais aspectos dos diferentes estágios do procedimento (pré injeção, peri injeção e pós injeção) e apresentamos nosso protocolo. A medida com maior evidência científica na profilaxia da endoftalmite é a aplicação de iodopovidona tópica pelo menos trinta segundos antes da injeção. (AU)


Intravitreal injection is the most widely performed ophthalmologic procedure in the world. This technique allows for delivering therapeutic substances to the posterior segment of the eye, being the route of choice for the treatment of most chorioretinal diseases. The most feared adverse event is post-injection endophthalmitis. Many measures have been described to lower the risk of this complication, with variable evidence. In view of the great number of injections performed at our ophthalmology practice at Hospital de Clínicas de Porto Alegre (HCPA), we searched the literature for available evidence on the best practice standards. We describe the available evidence for major aspects of the different stages of the procedure (pre-injection, peri-injection, and post-injection) and then introduce our protocol. The measure with most scientific evidence of efficacy in preventing endophthalmitis is topical povidone- iodine administration at least 30 seconds before the injection. (AU)


Subject(s)
Intravitreal Injections , Postoperative Complications , Perioperative Care , Anesthesia
4.
Article in Portuguese | LILACS | ID: biblio-883005

ABSTRACT

Glaucoma agudo é a apresentação mais sintomática dentro do quadro glaucomatoso, podendo evoluir com perda visual irreversível em poucas horas. Costuma acometer indivíduos com anatomia predisponente. Seu diagnóstico e início rápido do tratamento são fundamentais para preservação do prognóstico visual do paciente.


Acute glaucoma is the most symptomatic presentation of the glaucomatous disease, which can progress to irreversible blindness in just a few hours if left untreated. It typically occurs in patients with predisponent anatomy. It's prompt recognition and fast initiation of therapy is the mainstay to provide a good visual outcome for the patient.


Subject(s)
Glaucoma , Glaucoma, Angle-Closure/diagnosis , Glaucoma, Angle-Closure/drug therapy , Emergencies
5.
Neurobiol Learn Mem ; 120: 1-6, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25687693

ABSTRACT

Healthy neuronal function and synaptic modification require a concert of synthesis and degradation of proteins. Increasing evidence indicates that protein turnover mediated by proteasome activity is involved in long-term synaptic plasticity and memory. However, its role in different phases of memory remains debated, and previous studies have not examined the possible requirement of protein degradation in recognition memory. Here, we show that the proteasome inhibitor, lactacystin (LAC), infused into the CA1 area of the hippocampus at two specific time points during consolidation, impairs 24-retention of memory for object recognition in rats. Administration of LAC after retrieval did not affect retention. These findings provide the first evidence for a requirement of proteasome activity in recognition memory, indicate that protein degradation in the hippocampus is necessary during selective time windows of memory consolidation, and further our understanding of the role of protein turnover in memory formation.


Subject(s)
Hippocampus/physiology , Memory Consolidation/physiology , Proteasome Endopeptidase Complex/physiology , Recognition, Psychology/physiology , Acetylcysteine/analogs & derivatives , Acetylcysteine/pharmacology , Animals , CA1 Region, Hippocampal/drug effects , CA1 Region, Hippocampal/metabolism , CA1 Region, Hippocampal/physiology , Hippocampus/drug effects , Hippocampus/metabolism , Infusions, Intraventricular , Male , Proteasome Endopeptidase Complex/drug effects , Proteasome Endopeptidase Complex/metabolism , Proteolysis , Rats , Rats, Wistar , Retention, Psychology/physiology
6.
J Neural Transm (Vienna) ; 122(5): 709-19, 2015 May.
Article in English | MEDLINE | ID: mdl-25182413

ABSTRACT

Exposure to stressful events early in life may have permanent deleterious consequences on nervous system function and increase the susceptibility to psychiatric conditions later in life. Maternal deprivation, commonly used as a source of neonatal stress, impairs memory in adult rats and reduces hippocampal brain-derived neurotrophic factor (BDNF) levels. Inflammatory cytokines, such as interleukins (IL) and tumor necrosis factor-α (TNF-α) have been shown to be increased in the peripheral blood of patients with psychiatric disorders. The aim of the present study was to investigate the effects of maternal separation on the levels of IL-10 and TNF-α, and BDNF in the hippocampus and prefrontal cortex of adult rats. We also evaluated the potential ameliorating properties of topiramate and valproic acid on memory deficits and cytokine and BDNF changes associated with maternal deprivation. The results indicated that, in addition to inducing memory deficits, maternal deprivation increased the levels of IL-10 in the hippocampus, and TNF-α in the hippocampus and in the cortex, and decreased hippocampal levels of BDNF, in adult life. Neither valproic acid nor topiramate were able to ameliorate memory deficits or the reduction in BDNF induced by maternal separation. The highest dose of topiramate was able to reduce IL-10 in the hippocampus and TNF-α in the prefrontal cortex, while valproate only reduced IL-10 levels in the hippocampus. These findings may have implications for a better understanding of the mechanisms associated with alterations observed in adult life induced by early stressful events, and for the proposal of novel therapeutic strategies.


Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , Cytokines/metabolism , Hippocampus/metabolism , Maternal Deprivation , Memory Disorders/metabolism , Prefrontal Cortex/metabolism , Animals , Exploratory Behavior/drug effects , Exploratory Behavior/physiology , Fructose/analogs & derivatives , Fructose/pharmacology , Hippocampus/drug effects , Hippocampus/growth & development , Male , Memory Disorders/drug therapy , Memory Disorders/etiology , Prefrontal Cortex/drug effects , Prefrontal Cortex/growth & development , Psychotropic Drugs/pharmacology , Rats, Wistar , Recognition, Psychology/drug effects , Recognition, Psychology/physiology , Stress, Psychological/drug therapy , Stress, Psychological/etiology , Stress, Psychological/metabolism , Topiramate , Valproic Acid/pharmacology
7.
Mol Neurobiol ; 49(1): 222-33, 2014 Feb.
Article in English | MEDLINE | ID: mdl-23893294

ABSTRACT

We have recently shown that chronic treatment with cannabidiol (CBD) was able to recover memory deficits induced by brain iron loading in a dose-dependent manner in rats. Brain iron accumulation is implicated in the pathogenesis of neurodegenerative diseases, including Parkinson's and Alzheimer's, and has been related to cognitive deficits in animals and human subjects. Deficits in synaptic energy supply have been linked to neurodegenerative diseases, evidencing the key role played by mitochondria in maintaining viable neural cells and functional circuits. It has also been shown that brains of patients suffering from neurodegenerative diseases have increased expression of apoptosisrelated proteins and specific DNA fragmentation. Here, we have analyzed the expression level of brain proteins involved with mitochondrial fusion and fission mechanisms (DNM1L and OPA1), the main integral transmembrane protein of synaptic vesicles (synaptophysin), and caspase 3, an apoptosis-related protein, to gain a better understanding of the potential of CBD in restoring the damage caused by iron loading in rats. We found that CBD rescued iron-induced effects, bringing hippocampal DNM1L, caspase 3, and synaptophysin levels back to values comparable to the control group. Our results suggest that iron affects mitochondrial dynamics, possibly trigging synaptic loss and apoptotic cell death and indicate that CBD should be considered as a potential molecule with memory-rescuing and neuroprotective properties to be used in the treatment of cognitive deficits observed in neurodegenerative disorders.


Subject(s)
Cannabidiol/pharmacology , Caspase 3/biosynthesis , Dynamins/biosynthesis , Gene Expression Regulation/drug effects , Iron Overload/metabolism , Mitochondrial Dynamics/physiology , Neuroprotective Agents/pharmacology , Synaptophysin/biosynthesis , Animals , Brain/drug effects , Brain/metabolism , Cannabidiol/therapeutic use , Female , Iron Overload/prevention & control , Male , Mitochondria/drug effects , Mitochondria/metabolism , Mitochondrial Dynamics/drug effects , Pregnancy , Random Allocation , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...